Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
30757
Description
Study part: Pharmacodynamics. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (2)
- 6/19/18 6/19/18 -
- 9/20/21 9/20/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 19, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pharmacodynamics Pazopanib Macular Degeneration MD1103367
Similar models
Pharmacodynamics
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
PHARMACODYNAMICS - PD Prothrombin (PD FRAG)- 24 Hours
C0851347 (UMLS CUI-1)
C0033706 (UMLS CUI-2)
C0033706 (UMLS CUI-2)
CL Item
Day 7 (Day 7)
CL Item
Day 14 (Day 14)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS URINE -11-dehydrothromboxane B2 (PDU) Postdose at Day 7
C0851347 (UMLS CUI-1)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS - Bone Markers (PD BONE) 24 Hours at Day 14
C0851347 (UMLS CUI-1)
C0181734 (UMLS CUI-2)
C0181734 (UMLS CUI-2)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS - VEGF (PD VEGF) 24 Hours at Day 14
C0851347 (UMLS CUI-1)
C1256770 (UMLS CUI-2)
C1256770 (UMLS CUI-2)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS URINE -11-dehydrothromboxane B2 (PDU) Postdose at Day 15
C0851347 (UMLS CUI-1)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])